Mechanisms of selective α₁-inhibition in lipid metabolism: role of doxazosin, April 16, 1988DZAU, V. J.Journal of cardiovascular pharmacology. 1989, Vol 13, issn 0160-2446, 52 p., suppl. 2Conference Proceedings

Studies on YM-12617: a selective and potent antagonist of postsynaptic α₁-adrenoceptorsHONDA, K; TAKENAKA, T; MIYATA-OSAWA, A et al.Naunyn-Schmiedeberg's archives of pharmacology. 1985, Vol 328, Num 3, pp 264-272, issn 0028-1298Article

α-Blocker Use Is Associated With Decreased Risk of Sexual Dysfunction. Commentary. Authors' replyKUMAR, Rajeev; GADES, Naomi M; LIEBER, Michael M et al.Urology (Ridgewood, NJ). 2009, Vol 74, Num 1, pp 82-88, issn 0090-4295, 7 p.Article

Clinical settings for selective alpha-adrenergic receptor inhibition: rationale and management strategies, Naples FL, October 13-16, 1988TAYLOR, Stanley H.The American journal of medicine. 1989, Vol 87, Num 2, issn 0002-9343, 66 p., suppl. AConference Proceedings

Effects of YM-12617, an alpha adrenoceptor blocking agent, on electrical and mechanical properties of the guinea-pig mesenteric and pulmonary arteriesFUJII, K; KURIYAMA, H.The Journal of pharmacology and experimental therapeutics. 1985, Vol 235, Num 3, pp 764-770, issn 0022-3565Article

Nimodipine and inhibition of Alpha adrenergic activation of the isolated canine saphenous veinCOOKE, J. P; RIMELE, T. J; FLAVAHAN, N. A et al.The Journal of pharmacology and experimental therapeutics. 1985, Vol 234, Num 3, pp 598-602, issn 0022-3565Article

Cardiac and coronary effects of prazosin and phenoxybenzamine during coronary hypotensionJONES, C. E; LIANG, I. Y. S; MAULSBY, M. R et al.The Journal of pharmacology and experimental therapeutics. 1986, Vol 236, Num 1, pp 204-211, issn 0022-3565Article

Further investigations on the α₁-adrenoceptor blocking properties of AR-C 239 in ratsHUCHET, A.-M; ANDREJAK, M; LUCET, B et al.Clinical and experimental pharmacology and physiology. 1985, Vol 12, Num 5, pp 505-513, issn 0305-1870Article

Alpha-adrenolytic properties of apogalanthamine and azapetine analogsISHIDA, Y; SASAKI, Y; KUMURA, Y et al.Journal of pharmacobio-dynamics. 1985, Vol 8, Num 11, pp 917-923, issn 0386-846XArticle

No evidence for differences between pre- and post-junctional α₂-adrenoceptorsDOCHERTY, J. R; HYLAND, L.British journal of pharmacology. 1985, Vol 86, Num 2, pp 335-339, issn 0007-1188Article

Pharmacokinetics of moxisylyte in healthy volunteers after intravenous and oral administrationCOSTA, P; BRESSOLLE, F; BROMET-PETIT, M et al.Journal of pharmaceutical sciences. 1992, Vol 81, Num 12, pp 1223-1226, issn 0022-3549Article

Alpha₁ blockers : antihypertensives whose positive metabolic profile with regard to hyperinsulinaemia and lipid metabolism cannot be ignoredWAITE, M. A.Journal of internal medicine. Supplement. 1991, Vol 229, Num 735, pp 113-117, issn 0955-7873Article

The value of alpha-blockers in the management of hypertension : a practical viewMCINNES, G. T.Journal of human hypertension. 1991, Vol 5, Num 4, pp 313-316, issn 0950-9240, 4 p.Article

Comparison of the effects of propranolol and indoramin on self-report sexual response induced by exposure to erotic video sequence in female volunteersRILEY, A. J.Sexual and marital therapy. 1990, Vol 5, Num 1, pp 83-88, issn 0267-4653, 6 p.Article

Treatment of clomipramine-induced anorgasmia with yohimbinePRICE, J; GRUNHAUS, L. J.The Journal of clinical psychiatry. 1990, Vol 51, Num 1, pp 32-33, issn 0160-6689Article

Time course of thymoxamine reversal of phenylephrine-induced mydriasisWRIGHT, M. M; SKUTA, G. L; DRAKE, M. V et al.Archives of ophthalmology (1960). 1990, Vol 108, Num 12, pp 1729-1732, issn 0003-9950, 4 p.Article

Adverse effects of α1-adrenergic blocking drugsCARRUTHERS, S. G.Drug safety. 1994, Vol 11, Num 1, pp 12-20, issn 0114-5916Article

Anti-arrhythmic properties fo the α-adrenoceptor blocking drug indoraminJAMES, M. A; JONES, J. V.British journal of clinical pharmacology. 1991, Vol 32, Num 3, pp 375-378, issn 0306-5251Article

Hämodynamische Untersuchungen zur Wirkungskinetik von Phenoxybenzamin bei gesunden Personen und Patienten mit Hypertonie = Etudes hémodynamiques de la cinétique de l'action de la phénoxybenzamine chez des sujets en bonne santé et chez des malades hypertendus = Hemodynamic studies of phenoxybenzamine action kinetics in healthy subjects and hypertensive patientsGLÄNZER, K; VOGT, H. J; DÜSING, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 9, pp 1054-1057, issn 0004-4172Article

Computerized evaluation of Valsalvás maneuver before and during α-adrenoceptor blockade with alfuzosinMCALONEY, R; MITCHELL, H; DEERING, A. H et al.Journal of pharmacological methods. 1987, Vol 18, Num 2, pp 163-177, issn 0160-5402Article

Le point sur l'éjaculation prématurée = Causes and present conception about premature ejaculationTORDJMAN, G.Cahiers de sexologie clinique. 1987, Vol 13, Num 78, pp 19-23, issn 0336-5913Article

Putting the A' in atypical: does α₂-adrenoceptor antagonism account for the therapeutic advantage of new antipsychotics?NUTT, D. J.Journal of psychopharmacology (Oxford). 1994, Vol 8, Num 4, pp 193-195, issn 0269-8811Article

The safety of inravenous phentolamine administration in patients with neuropathic painYORAM SHIR; CAMERON, L. B; RAJA, S. N et al.Anesthesia and analgesia. 1993, Vol 76, Num 5, pp 1008-1011, issn 0003-2999Article

The place of alpha blockers in the antihypertensive armamentariumCARRUTHERS, S. G.Journal of clinical pharmacology. 1993, Vol 33, Num 3, pp 260-263, issn 0091-2700Conference Paper

Les alpha-bloquants = Alpha blocking agentSAUTOU, V; CHAFIK, H; TERRISSE, M. P et al.Lyon pharmaceutique. 1992, Vol 43, Num 2, pp 83-99, issn 0024-7804Article